Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Advanced Pd-catalyzed synthesis for trifluoromethyl chromone quinoline intermediates. Offers scalable production and cost efficiency for pharmaceutical supply chains.
Efficient one-pot synthesis of 3-cyanoindoles using copper catalysis. Reduces steps and toxic reagents for pharmaceutical intermediate manufacturing.
Novel sulfur-promoted synthesis for 1,2,4-triazole compounds. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.
Patent CN112920173A details a chiral phosphoric acid catalyzed synthesis of cytotoxic chroman derivatives, offering high enantioselectivity and scalable manufacturing for oncology drug development.
Novel palladium-catalyzed method for indolone structures reduces steps and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN115260080B reveals efficient Pd-catalyzed route. Reduces costs and improves supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN118126005B reveals metal-free synthesis for fluorine heterocycles. Delivers cost reduction in pharmaceutical manufacturing and high-purity intermediates.
Patent CN115353511A details a safe Pd-catalyzed multicomponent route avoiding toxic CO gas, offering cost reduction in API manufacturing and scalable production.
Patent CN115353482B reveals metal-free synthesis. Offers cost reduction and supply reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN115403505B details a novel palladium-catalyzed route using sulfonyl chloride. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113045503B details a novel Pd-catalyzed carbonylation for 2-CF3-quinazolinones. This method offers high yields, mild conditions, and cost-effective API intermediate manufacturing.
Patent CN107163062B reveals mild sultone synthesis. Offers supply chain reliability and cost reduction for pharmaceutical intermediate manufacturing.
Novel one-step synthesis patent CN110156815A offers high purity heterocyclic intermediates. Efficient process reduces costs and ensures supply chain continuity for global pharmaceutical manufacturing.
Novel glucose-based route for trifluoromethyl triazoles offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115286578B reveals metal-free synthesis for trifluoromethyl pyrazoles. This method offers substantial cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112538054B details a novel Pd-catalyzed carbonylation route for 1,2,4-triazole-3-ones, offering cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN118206512A details a palladium-catalyzed route for 3-alkynylbenzofuran. Offers high purity and scalable manufacturing for pharmaceutical supply chains.
Patent CN119118976A reveals a nickel-catalyzed route for thioester pyrones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel patent CN113698392B details high-yield Pranlukast intermediate synthesis. Offers mild conditions and supply chain stability for global API manufacturing partners.
Novel cobalt-catalyzed method for 1H-indole-2-amide compounds. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.